Effect of weight loss on proteinuria in adults with type 2 diabetes: A real-world study

被引:2
|
作者
Ren, Wenqian [1 ]
Gong, Yujia [1 ]
Zhen, Qin [1 ]
Gu, Liping [1 ]
Yang, Jiaying [1 ]
Kang, Mei [2 ]
Zhang, Aifang [1 ]
Shen, Tingting [1 ]
Wang, Yufan [1 ]
Liu, Fang [1 ,3 ]
Li, Na [1 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Endocrinol & Metab, Shanghai 200080, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Clin Med Res Ctr, Sch Med, Shanghai 200080, Peoples R China
[3] 100 Haining Rd, Shanghai 200080, Peoples R China
基金
中国国家自然科学基金;
关键词
Body weight; Proteinuria; Regression; Type; 2; diabetes; CHRONIC KIDNEY-DISEASE; BODY-MASS INDEX; RISK-FACTORS; OBESITY; PREVALENCE; MANAGEMENT;
D O I
10.1016/j.diabres.2023.111021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To assess the impact of weight loss on proteinuria in patients with type 2 diabetes (T2DM) in real-world settings. Methods: A total of 1054 participants were categorized based on weight change from baseline to one-year followup: weight gain (>= 3%), stable weight, or weight loss (>= 3%). Proteinuria outcomes were defined as urinary albumin/creatinine ratio (UACR) progression (>= 30 % increase), UACR regression (>= 30 % reduction), or UACR stable. Ordered logistic regression analysis evaluated the relationship between weight loss and UACR regression. Results: Of the 1054 participants, 44.5 % were overweight, and 24.1 % were obese. Patients with obesity were at higher risk of developing proteinuria (OR, 1.783; 95 %CI, 1.195 to 2.659). Weight loss was associated with an 83.3 % increase in UACR regression compared to weight gain (OR, 1.833; 95 % CI, 1.262 to 2.663; P = 0.001). This association remained consistent across most subgroups and stronger in males (P for interaction = 0.023), with a 6 % UACR regression for every 1 kg weight loss (OR, 1.06; 95 % CI, 1.02 to 1.10; P = 0.003). Conclusions: Our real-world study reveals that weight reduction is associated with UACR regression in patients with T2DM, regardless of the approach used for weight management, and the association was much stronger in males.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Glycaemic and weight-loss outcomes of graded doses of canagliflozin in type 2 diabetes - a real-world study
    Dutta, Deep
    Sharma, Meha
    Dhall, Anil
    Aggarwal, Sameer
    Khandelwal, Deepak
    CLINICAL DIABETOLOGY, 2020, 9 (06): : 442 - 453
  • [2] Weight Management in Patients with Type 2 Diabetes: a Multidisciplinary Real-world Approach
    Hamdy, Osama
    Ashrafzadeh, Sahar
    Mottalib, Adham
    CURRENT DIABETES REPORTS, 2018, 18 (09)
  • [3] REAL-world evidence of risk factors and comorbidities in YOUNG Indian adults with type 2 diabetes mellitus: A REAL YOUNG (diabetes) study
    Saboo, Banshi
    Agarwal, Sanjay
    Gupta, Sunil
    Makkar, Brij
    Panneerselvam, A.
    Sahoo, Abhay Kumar
    Ramchandani, G. D.
    Das, Sambit
    Erande, Suhas
    Kadam, Yogesh
    Abhyankar, Mahesh, V
    Revankar, Santosh
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (09) : 3444 - 3452
  • [4] Treatment Patterns and Glycaemic Control Between 2015 and 2019 in Tianjin, China: A Real-World Study of Adults with Type 2 Diabetes
    Zhang, Qiumei
    Fan, Yaqing
    Liu, Xixi
    Zhang, Minlu
    Zhang, Jiewen
    Du, Qin
    Kang, Lei
    Chen, Liming
    DIABETES THERAPY, 2025, 16 (01) : 1 - 14
  • [5] Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study
    van Houtum, William
    Schrombges, Patrick
    Amadid, Hanan
    van Bon, Arianne C.
    Braae, Uffe C.
    Hoogstraten, Charlotte
    Herrings, Hans
    DIABETES THERAPY, 2024, 15 (08) : 1749 - 1768
  • [6] Pharmacotherapy for weight loss in adults with type 2 diabetes: a systematic review of randomised controlled trials
    Coelho, Claudia
    Agius, Rachel
    Crane, James
    McGowan, Barbara
    BRITISH JOURNAL OF DIABETES, 2021, 21 (01): : 20 - U34
  • [7] Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes
    Patti, Angelo Maria
    Giglio, Rosaria Vincenza
    Allotta, Alberto
    Bruno, Andreina
    Di Bella, Tommaso
    Stoian, Anca Pantea
    Ciaccio, Marcello
    Rizzo, Manfredi
    BIOMEDICINES, 2023, 11 (05)
  • [8] Glycemic and weight control in people with type 2 diabetes: A real-world observational study in primary care
    Orozco-Beltran, D.
    Mata-Cases, M.
    Artola-Menendez, S.
    Alvarez-Guisasola, F.
    Cebrian-Cuenca, A. M.
    Perez, A.
    PRIMARY CARE DIABETES, 2025, 19 (01) : 7 - 14
  • [9] A Real-World Study of the Effectiveness and Safety of Semaglutide for Weight Loss
    Tzoulis, Ploutarchos
    Batavanis, Michael
    Baldeweg, Stephanie
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [10] PIONEER REAL Italy: Real-World Usage of Once-Daily Oral Semaglutide in Adults with Type 2 Diabetes
    Manti, Roberta
    De Cosmo, Salvatore
    Desenzani, Paolo
    Ferrara, Lidia
    Girelli, Angela
    Memoli, Giuseppe
    Bisio, Alessandro
    Braae, Uffe Christian
    Deinega, Alisa
    Berra, Cesare
    PIONEER REAL Italy Investigators, Massimiliano
    DIABETES THERAPY, 2025, : 1019 - 1032